European Organisation for Research and Treatment of Cancer

Content by European Organisation for Research and Treatment of Cancer

Updated |3 min read

Postsurgery Immunotherapy Doesn’t Improve Survival in Breast Cancer

Adding atezolizumab immunotherapy to postsurgery chemotherapy doesn’t have the same benefits as the pre-surgery regimen
Page 1 of 1